{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:20:09Z","timestamp":1790943609333,"version":"4.1.0"},"reference-count":148,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,2,20]]},"abstract":"<jats:p>Ovarian carcinogenesis, as in most cancers, involves multiple genetic alterations. A great deal has been learned about proteins and pathways important in the early stages of malignant transformation and metastasis, as derived from studies of individual tumors, microarray data, animal models, and inherited disorders that confer susceptibility. However, a full understanding of the earliest recognizable events in epithelial ovarian carcinogenesis is limited by the lack of a well-defined premalignant state common to all ovarian subtypes and by the paucity of data from early-stage cancers. Evidence suggests that ovarian cancers can progress both through a stepwise mutation process (low-grade pathway) and through greater genetic instability that leads to rapid metastasis without an identifiable precursor lesion (high-grade pathway). In this review, we discuss many of the genetic and molecular disorders in each key process that is altered in cancer cells, and we present a model of ovarian pathogenesis that incorporates the role of tumor cell mutations and factors in the host microenvironment important to tumor initiation and progression.<\/jats:p>","DOI":"10.1200\/jco.2006.07.9970","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T01:56:36Z","timestamp":1200362196000},"page":"995-1005","source":"Crossref","is-referenced-by-count":343,"title":["Early Events in the Pathogenesis of Epithelial Ovarian Cancer"],"prefix":"10.1200","volume":"26","author":[{"suffix":"Jr","given":"Charles N.","family":"Landen","sequence":"first","affiliation":[{"name":"From the Department of Gynecologic Oncology and the Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[{"name":"From the Department of Gynecologic Oncology and the Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[{"name":"From the Department of Gynecologic Oncology and the Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.43"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012158"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2240"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Auersperg N, Wong AS, Choi KC, et al: Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocr Rev 22:255,2001-288,","DOI":"10.1210\/er.22.2.255"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.4161\/cc.4.8.1906"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO;2-T"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-200110000-00005"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2001.01027.x"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2003.13605.x"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950615)75:12<2891::AID-CNCR2820751216>3.0.CO;2-B"},{"key":"R11","unstructured":"Pere H, Tapper J, Seppala M, et al: Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis. Cancer Res 58:4274,1998-4276,"},{"key":"R12","unstructured":"Muto MG, Welch WR, Mok SC, et al: Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 55:490,1995-492,"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213335.40358.47"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2005.09.014"},{"key":"R14A","doi-asserted-by":"publisher","DOI":"10.1080\/09513590400014354"},{"key":"R14B","doi-asserted-by":"crossref","unstructured":"Capen CC: Mechanisms of hormone-mediated carcinogenesis of the ovary. Toxicol Pathol 32:1,2004-5, (suppl 2)","DOI":"10.1080\/01926230490462075"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92335-X"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116427"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117296"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf048"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(90)90160-Q"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113791"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.877335"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3552(05)80140-3"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.23.1774"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00226-8"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000128139.92313.74"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.17.1459"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5628"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8506"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0044"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01384.x"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20478"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13203"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1593"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6512"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117055"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(83)90023-9"},{"key":"R37","unstructured":"Seeger H, Wallwiener D, Mueck AO: Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? Eur J Gynaecol Oncol 27:139,2006-141,"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-6-851"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600154"},{"key":"R40","unstructured":"Altinoz MA, Korkmaz R: NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51:239,2004-247,"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70597-5"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199809000-00012"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207959"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1038\/nature04296"},{"key":"R45","unstructured":"Shridhar V, Lee J, Pandita A, et al: Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61:5895,2001-5904,"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00660.x"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.13.990"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11310"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.02.022"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1038\/ng0495-439"},{"key":"R51","unstructured":"Baldwin RL, Nemeth E, Tran H, et al: BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study. Cancer Res 60:5329,2000-5333,"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.7.564"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.18.1396"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00615-3"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb02195.x"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340633"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10257"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(01)00002-2"},{"key":"R60","unstructured":"Connolly DC, Bao R, Nikitin AY, et al: Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389,2003-1397,"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1038\/nm1173"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63708-X"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000227787.24587.d1"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.153"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052985"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200404000-00009"},{"key":"R67","doi-asserted-by":"crossref","unstructured":"Crispens MA, Bodurka D, Deavers M, et al: Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99:3,2002-10,","DOI":"10.1097\/00006250-200201000-00003"},{"key":"R68","unstructured":"Mok SC, Bell DA, Knapp RC, et al: Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 53:1489,1993-1492,"},{"key":"R69","unstructured":"Teneriello MG, Ebina M, Linnoila RI, et al: p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103,1993-3108,"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.6.484"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.18.1513"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.11.4961"},{"key":"R73","unstructured":"Skilling JS, Sood A, Niemann T, et al: An abundance of p53 null mutations in ovarian carcinoma. Oncogene 13:117,1996-123,"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.19.9267"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/111.3.311"},{"key":"R76","unstructured":"Singer G, Rebmann V, Chen YC, et al: HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 9:4460,2003-4464,"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21902"},{"key":"R78","unstructured":"Dodson MK, Hartmann LC, Cliby WA, et al: Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 53:4456,1993-4460,"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208298"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603003"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1110"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(99)00192-2"},{"key":"R83","unstructured":"Obata K, Morland SJ, Watson RH, et al: Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58:2095,1998-2097,"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1410"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.09.001"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208159"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6851"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.08.012"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.53"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1992.02060291.x"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6308"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690826"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)63362-4"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.7.522"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.1.214"},{"key":"R97","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240450108"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0014"},{"key":"R99","unstructured":"Marks JR, Davidoff AM, Kerns BJ, et al: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979,1991-2984,"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.041"},{"key":"R101","unstructured":"Hu L, Hofmann J, Lu Y, et al: Inhibition of phosphatidylinositol 3\u2032-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 62:1087,2002-1092,"},{"key":"R102","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01151-6"},{"key":"R103","unstructured":"Huang S, Robinson JB, Deguzman A, et al: Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60:5334,2000-5339,"},{"key":"R104","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.3.12.1235"},{"key":"R105","doi-asserted-by":"publisher","DOI":"10.1002\/path.1191"},{"key":"R106","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgl115"},{"key":"R107","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00318-8"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191367098"},{"key":"R109","doi-asserted-by":"crossref","unstructured":"Wang E, Ngalame Y, Panelli MC, et al: Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clin Cancer Res 11:113,2005-122,","DOI":"10.1158\/1078-0432.113.11.1"},{"key":"R110","doi-asserted-by":"publisher","DOI":"10.1038\/nm0195-27"},{"key":"R111","unstructured":"Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65,1992-71,"},{"key":"R112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.10.062"},{"key":"R113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114322"},{"key":"R114","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823562"},{"key":"R115","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.6.447"},{"key":"R116","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A"},{"key":"R117","unstructured":"Cooper BC, Ritchie JM, Broghammer CL, et al: Preoperative serum vascular endothelial growth factor levels: Significance in ovarian cancer. Clin Cancer Res 8:3193,2002-3197,"},{"key":"R118","doi-asserted-by":"crossref","unstructured":"Xu L, Fidler IJ: Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 12:97,2000-106,","DOI":"10.3727\/096504001108747567"},{"key":"R119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.12.011"},{"key":"R120","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(03)00321-4"},{"key":"R121","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0589"},{"key":"R122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0530"},{"key":"R123","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj414"},{"key":"R124","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026510130114"},{"key":"R125","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3700"},{"key":"R126","unstructured":"Belotti D, Paganoni P, Manenti L, et al: Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation. Cancer Res 63:5224,2003-5229,"},{"key":"R127","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910580110"},{"key":"R128","doi-asserted-by":"crossref","unstructured":"Herrera CA, Xu L, Bucana CD, et al: Expression of metastasis-related genes in human epithelial ovarian tumors. Int J Oncol 20:5,2002-13,","DOI":"10.3892\/ijo.20.1.5"},{"key":"R129","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2338"},{"key":"R130","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.15.1134"},{"key":"R131","doi-asserted-by":"publisher","DOI":"10.1038\/nm1447"},{"key":"R132","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1698"},{"key":"R133","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1820"},{"key":"R134","unstructured":"Ben-Hur H, Gurevich P, Huszar M, et al: Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors. Eur J Gynaecol Oncol 21:141,2000-145,"},{"key":"R135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.8.4510"},{"key":"R136","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.20307"},{"key":"R137","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0060093"},{"key":"R138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020177"},{"key":"R139","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.5.9.1193"},{"key":"R140","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1098"},{"key":"R141","unstructured":"Emerich J, Konefka T, Dudziak M, et al: [The value of peritoneal cytology in the staging of ovarian cancer]. Ginekol Pol 68:74,1997-77,"},{"key":"R142","doi-asserted-by":"publisher","DOI":"10.1038\/nrc727"},{"key":"R143","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L"},{"key":"R144","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(03)00068-6"},{"key":"R145","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0021"},{"key":"R146","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.07.9970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T20:54:40Z","timestamp":1684184080000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.07.9970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,20]]},"references-count":148,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,2,20]]}},"alternative-id":["10.1200\/JCO.2006.07.9970"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.07.9970","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,20]]}}}